BP000343-HOR-262: Salmon Calcitonin Acetate
Purity> 98%, by SDS-PAGE and RP-HPLC.BP001528-PRO-796: Recombinant Human C-Terminal Binding Protein 1 (CTBP1)
Source: E. coli-derived.
Purity: > 90.0% as determined by SDS-PAGE.PA001353-PA1400: Fractalkine/CX3CL1 Polyclonal Antibody
Rabbit Polyclonal Antibody;
Applications: WB;
Reactivity: Human;
Isotype: Rabbit IgG.PA001353-PA1401: Fractalkine/CX3CL1 Polyclonal Antibody
Rabbit Polyclonal Antibody;
Applications: WB, IHC-P, IHC-F;
Reactivity: Mouse, Rat;
Isotype: Rabbit IgG.BP000273-C119: Recombinant Human C-X-C Motif Chemokine 11 (CXCL11) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000273-CHM-232: Recombinant Human C-X-C Motif Chemokine 11 (CXCL11) Protein, His Tag
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE.BP000273-CHM-334: Recombinant Human C-X-C Motif Chemokine 11 (CXCL11) Protein
Source: E. coli-derived.
ED50 range=1-10 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg determined by the dose dependent chemotaxis of human lymphocytes cultured in the presence of IL-2.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000289-C058: Recombinant Human C-X-C Motif Chemokine Ligand 14 (CXCL14) Protein
Source: E. coli-derived.
Purity:> 95% by SEC-HPLC and reducing SDS-PAG.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000289-CHM-001: Recombinant Human C-X-C Motif Chemokine Ligand 14 (CXCL14) Protein
Source: E. coli-derived.
The ED50 of CXCL14 as determined by its ability to induce calcium flux of prostaglandin E2 treated THP1 human acute monocytic leukemia cells was 1.0-10.0 ug/ml.
N-terminal sequence analysis: Ser-Lys-Cys-Lys-Cys.
Predicted molecular mass: 9.4 kDa.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000289-CHM-007: Recombinant Mouse C-X-C Motif Chemokine Ligand 14 (CXCL14) Protein
Source: E. coli-derived.
The ED50 of CXCL14 as determined by its ability to chemoattract activated monocytes was using a concentration range of 1.0-10.0 ug/ml.
Purity: > 95% by SDS-PAGE and RP-HPLC.